These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25869370)

  • 1. Prescription opioid epidemic and infant outcomes.
    Patrick SW; Dudley J; Martin PR; Harrell FE; Warren MD; Hartmann KE; Ely EW; Grijalva CG; Cooper WO
    Pediatrics; 2015 May; 135(5):842-50. PubMed ID: 25869370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure.
    Sanlorenzo LA; Cooper WO; Dudley JA; Stratton S; Maalouf FI; Patrick SW
    Hosp Pediatr; 2019 Aug; 9(8):569-575. PubMed ID: 31262946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
    Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
    BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male Sex Associated With Increased Risk of Neonatal Abstinence Syndrome.
    Charles MK; Cooper WO; Jansson LM; Dudley J; Slaughter JC; Patrick SW
    Hosp Pediatr; 2017 Jun; 7(6):328-334. PubMed ID: 28465360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis.
    Ko JY; Yoon J; Tong VT; Haight SC; Patel R; Rockhill KM; Luck J; Shapiro-Mendoza C
    Drug Alcohol Depend; 2021 Jun; 223():108704. PubMed ID: 33894458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018.
    Kelty EA; Cumming CN; Preen DB
    Pharmacotherapy; 2022 May; 42(5):405-410. PubMed ID: 35342965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013.
    Warren MD; Miller AM; Traylor J; Bauer A; Patrick SW;
    MMWR Morb Mortal Wkly Rep; 2015 Feb; 64(5):125-8. PubMed ID: 25674995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada.
    Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R
    PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
    Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
    J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
    Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
    Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
    [No Abstract]   [Full Text] [Related]  

  • 13. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure.
    Faherty LJ; Matone M; Passarella M; Lorch S
    Matern Child Health J; 2018 Jun; 22(6):841-848. PubMed ID: 29417369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Predictive Value of Administrative Data for Neonatal Abstinence Syndrome.
    Maalouf FI; Cooper WO; Stratton SM; Dudley JA; Ko J; Banerji A; Patrick SW
    Pediatrics; 2019 Jan; 143(1):. PubMed ID: 30514781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Neonatal Abstinence Syndrome Epidemic and Associated Predictors in Nevada: A Statewide Audit, 2016-2018.
    Batra K; Cruz P; Cross CL; Bhandari N; Abdulla F; Pharr JR; Buttner MP
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33396848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
    Ma J; Sahasranaman V; Kirby RS; Boaz T
    J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013.
    Okoroh EM; Gee RE; Jiang B; McNeil MB; Hardy-Decuir BA; Zapata AL
    Matern Child Health J; 2017 Jul; 21(7):1479-1487. PubMed ID: 28168591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization.
    Percy Z; Brokamp C; McAllister JM; Ryan P; Wexelblatt SL; Hall ES
    J Pediatr; 2020 Jul; 222():52-58.e1. PubMed ID: 32423682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
    Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
    BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.